Skip to main content
. 2020 Jun 4;20(10):1172–1181. doi: 10.1016/S1473-3099(20)30153-5

Table 2.

DTR, CR, and ECR episodes and site-specific DOT by species*

DTR episodes DTR DOT CR episodes CR DOT ECR episodes ECR DOT
Pseudomonas aeruginosa
Urinary (5 DOT) 127 635 715 3575 244 1220
Intra-abdominal (7 DOT) 17 119 74 518 16 112
Lower respiratory (8 DOT) 278 2224 1028 8224 396 3168
Skin and soft tissue (5 DOT) 48 240 233 1165 125 625
Other (5 DOT) 13 65 74 370 31 155
Primary bloodstream (14 DOT) 33 462 137 1918 38 532
Secondary bloodstream (14 DOT) 6 84 20 280 6 84
Total 522 3829 2281 16 050 856 5896
DOT per 10 000 encounters .. 12·8 .. 53·6 .. 19·7
Acinetobacter baumannii complex
Urinary (5 DOT) 76 380 39 195 80 400
Intra-abdominal (7 DOT) 11 77 5 35 9 63
Lower respiratory (8 DOT) 173 1384 102 816 183 1464
Skin and soft tissue (5 DOT) 64 320 54 270 88 440
Other (5 DOT) 21 105 9 45 27 135
Primary bloodstream (14 DOT) 40 560 16 224 44 616
Secondary bloodstream (14 DOT) 8 112 4 56 4 56
Total 393 2938 229 1641 435 3174
DOT per 10 000 encounters .. 9·8 .. 5·5 .. 10·6
Enterobacteriaceae spp
Urinary (5 DOT) 222 1110 219 1095 5589 27 945
Intra-abdominal (7 DOT) 14 98 34 238 249 1743
Lower respiratory (8 DOT) 99 792 73 584 915 7320
Skin and soft tissue (5 DOT) 39 195 35 175 573 2865
Other (5 DOT) 10 50 16 80 134 670
Primary bloodstream (14 DOT) 52 728 56 784 774 10 836
Secondary bloodstream (14 DOT) 20 280 6 84 357 4998
Total 456 3253 439 3040 8591 56 377
DOT per 10 000 encounters .. 10·9 .. 10·1 .. 188·2

Data are n or n per 10 000 encounters. DTR=difficult-to-treat resistance. DOT=days of therapy. CR=carbapenem resistant. ECR=extended-spectrum cephalosporin-resistant.

*

Hierarchical algorithm for generating market size estimates was applied to a dataset that included only the organism of interest individually; all categories (DTR, CR, and ECR) are mutually exclusive groups (CR category excludes episodes classified as DTR and ECR excludes episodes classified as DTR or CR); the term CR specifically refers to the subset of CR pathogens against which at least one first-line drug is active and hence not DTR.

Enterobacteriaceae spp is a summation of eight species evaluated individually (appendix p 11).